Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C O Tacket

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
The Journal of Infectious Diseases|August 1, 1986
Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccinesC O Tacket, C Ferreccio, J B Robbins, et al.
The Journal of Infectious Diseases|February 1, 1995
Heterogeneity of enteroaggregative Escherichia coli virulence demonstrated in volunteersJ P Nataro, Y Deng, S Cookson, et al.
The American Journal of Tropical Medicine and Hygiene|May 1, 1997
Volunteer studies investigating the safety and efficacy of live oral El Tor Vibrio cholerae O1 vaccine strain CVD 111C O Tacket, K L Kotloff, G Losonsky, et al.
Journal of Virology|October 1, 1993
Dengue virus-specific human CD4+ T-lymphocyte responses in a recipient of an experimental live-attenuated dengue virus type 1 vaccine: bulk culture proliferation, clonal analysis, and precursor frequency determinationS Green, I Kurane, R Edelman, et al.
American Journal of Epidemiology|January 1, 1991
Assessment of the prevalence and risk factors for human immunodeficiency virus type 1 (HIV-1) infection among college students using three survey methodsK L Kotloff, C O Tacket, J D Clemens, et al.
Vaccine|January 1, 1992
Initial safety and immunogenicity studies of an oral recombinant adenohepatitis B vaccineC O Tacket, G Losonsky, M D Lubeck, et al.
Infection and Immunity|June 1, 1990
Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21aC O Tacket, B Forrest, R Morona, et al.
The Journal of Clinical Investigation|September 1, 1993
Role of the eaeA gene in experimental enteropathogenic Escherichia coli infectionM S Donnenberg, C O Tacket, S P James, et al.
Infection and Immunity|February 1, 1992
Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteersC O Tacket, D M Hone, R Curtiss, et al.
The Journal of Infectious Diseases|December 1, 1994
A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humansR Edelman, C O Tacket, S S Wasserman, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
The Journal of Infectious Diseases|August 1, 1986
Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccinesC O Tacket, C Ferreccio, J B Robbins, et al.
The Journal of Infectious Diseases|February 1, 1995
Heterogeneity of enteroaggregative Escherichia coli virulence demonstrated in volunteersJ P Nataro, Y Deng, S Cookson, et al.
The American Journal of Tropical Medicine and Hygiene|May 1, 1997
Volunteer studies investigating the safety and efficacy of live oral El Tor Vibrio cholerae O1 vaccine strain CVD 111C O Tacket, K L Kotloff, G Losonsky, et al.
Journal of Virology|October 1, 1993
Dengue virus-specific human CD4+ T-lymphocyte responses in a recipient of an experimental live-attenuated dengue virus type 1 vaccine: bulk culture proliferation, clonal analysis, and precursor frequency determinationS Green, I Kurane, R Edelman, et al.
American Journal of Epidemiology|January 1, 1991
Assessment of the prevalence and risk factors for human immunodeficiency virus type 1 (HIV-1) infection among college students using three survey methodsK L Kotloff, C O Tacket, J D Clemens, et al.
Vaccine|January 1, 1992
Initial safety and immunogenicity studies of an oral recombinant adenohepatitis B vaccineC O Tacket, G Losonsky, M D Lubeck, et al.
Infection and Immunity|June 1, 1990
Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21aC O Tacket, B Forrest, R Morona, et al.
The Journal of Clinical Investigation|September 1, 1993
Role of the eaeA gene in experimental enteropathogenic Escherichia coli infectionM S Donnenberg, C O Tacket, S P James, et al.
Infection and Immunity|February 1, 1992
Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteersC O Tacket, D M Hone, R Curtiss, et al.
The Journal of Infectious Diseases|December 1, 1994
A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humansR Edelman, C O Tacket, S S Wasserman, et al.
Pageof 9